Unifying heterogeneous expression data to predict targets for CAR-T cell therapy
Chimeric antigen receptor (CAR) T-cell therapy combines antigen-specific properties of monoclonal antibodies with the lytic capacity of T cells. An effective and safe CAR-T cell therapy strategy relies on identifying an antigen that has high expression and is tumor specific. This strategy has been s...
Enregistré dans:
Auteurs principaux: | , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Taylor & Francis Group
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/bf7f740860484a71a617907389cbe23f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|